Julie Zissimopoulos, PhD

Julie M. Zissimopoulos serves as the Associate Director of the Leonard D. Schaeffer Center for Health Policy and Economics, one of the nation’s premier health policy research institutions. She co-directs the National Institute on Aging funded Resource Center for Minority Aging Research and is a network associate of the MacArthur Foundation Research Network on an Aging Society. She was previously an associate professor of research at the University of Southern California and prior to that, a senior economist at the RAND Corporation. She specializes in the economics of aging. Topics of special interest are savings and wealth, labor force behavior, financial and non-financial support between generations of family members and medical expenditures at older ages. Dr. Zissimopoulos’ research sponsors have included the National Institute on Aging and the Social Security Administration. She is a frequent speaker on the economics of aging and her work has been featured in the Los Angeles Times, on California Public Radio, PBS Newshour, and other media. Dr. Zissimopoulos received her B.A. summa cum laude from Boston College and a Ph.D. in economics from the University of California, Los Angeles.

• The United States Cost of Dementia Model: Quantifying Current and Future Impacts of Alzheimer?s Disease and Related Dementias
  NIH · U01AG086827 · Jun 1, 2024 – Mar 31, 2029 · Role: Principal Investigator
• Use and Impact of Novel and Repurposed Therapeutics for Alzheimer's Disease and Related Dementia in the United States
  NIH · R33AG081811 · Apr 15, 2023 – Mar 31, 2028 · Role: Principal Investigator
• Use and Impact of Novel and Repurposed Therapeutics for Alzheimer's Disease and Related Dementia in Diverse Populations
  NIH · R61AG081811 · Apr 1, 2023 – Mar 31, 2025 · Role: Principal Investigator
• Center for Advancing Sociodemographic and Economic Study of Alzheimer's Disease and Related Dementias (CeASES-ADRD)
  NIH · P30AG066589 · Jul 16, 2020 – Aug 31, 2027 · Role: Principal Investigator
• Effectiveness of therapeutics and health care services in reducing racial disparities in Alzheimer's disease
  NIH · R01AG055401 · Sep 30, 2017 – May 31, 2021 · Role: Principal Investigator
• Racial Disparities in the Health of Caregivers for Persons with Alzheimer's Disease
  NIH · R03AG054120 · Aug 15, 2016 – May 31, 2018 · Role: Principal Investigator
• University of Southern California Resource Center for Aging and Dementia Research (USC RCAD)
  NIH · P30AG043073 · Sep 1, 2012 – Jun 30, 2028 · Role: Co-Principal Investigator
• Family Transfer Behavior in the HRS and AHEAD
  NIH · R03AG020095 · Sep 1, 2002 – Aug 31, 2004 · Role: Principal Investigator
• RAND Postdoctoral Training Program in the Study of Aging Renewal
  NIH · T32AG000244 · Sep 30, 1994 – Apr 30, 2026 · Role: Co-Principal Investigator

• Heterogeneous responses to risk-adjustment reform: evidence from dementia diagnosis in Medicare Advantage. Health Aff Sch. 2026 Jul; 4(7):qxag167.. View in PubMed
• The cost of dementia in the United States in 2026. Alzheimers Dement. 2026 Jun; 22(6):e71480.. View in PubMed
• A dynamic microsimulation method for estimating dementia costs in the United States. Alzheimers Dement. 2026 Jun; 22(6):e71549.. View in PubMed
• A scoping review of population-based dementia registries: advancing research, care, and policy. Alzheimers Dement. 2025 11; 21(11):e70938.. View in PubMed
• Role of PCPs in diagnosing dementia in traditional Medicare and Medicare Advantage. Alzheimers Dement. 2025 10; 21(10):e14559.. View in PubMed
• Long-term value of lecanemab to individuals and families. Alzheimers Dement (N Y). 2025 Jul-Sep; 11(3):e70151.. View in PubMed
• Real-World Evidence of Brexpiprazole Use and 6-Month Mortality, Hospitalization, and Emergency Department Visits Among Persons With Dementia. Neurology. 2025 Aug 12; 105(3):e213717.. View in PubMed
• Prevalence of dementia diagnoses in a safety net health system. Alzheimers Dement. 2025 04; 21(4):e70174.. View in PubMed
• Subjective Cognitive Impairment (SCI) and Future Dementia Risk in the National Health and Aging Trends Study (NHATS) During 2012-2019. J Aging Health. 2025 Mar; 37(3-4_suppl):76S-90S.. View in PubMed
• Association of Dementia Severity at Diagnosis With Health Care Utilization and Costs Around the Time of Incident Diagnosis. Innov Aging. 2025; 9(3):igaf005.. View in PubMed
• Relation of income to trends in well-being by age: implications for the future older “forgotten” lower middle class. Health Aff Sch. 2025 Feb; 3(2):qxae183.. View in PubMed
• After Risk-Adjustment Change, Dementia Diagnoses Increased In Medicare Advantage Relative To Traditional Medicare. Health Aff (Millwood). 2025 01; 44(1):81-89.. View in PubMed
• Warfarin Versus Non-Vitamin K Inhibitors Medications and Cognitive Disease Progression in Atrial Fibrillation. J Cardiovasc Nurs. 2025 Sep-Oct 01; 40(5):452-460.. View in PubMed
• Dementia severity at incident diagnosis in a population representative sample of older Americans. Alzheimers Dement (N Y). 2024 Jul-Sep; 10(3):e12491.. View in PubMed
• Population Dementia Incidence and Direct Oral Anticoagulant Use in a Representative Population With Atrial Fibrillation. Neurology. 2024 07 09; 103(1):e209568.. View in PubMed
• Analysis of agreement between measures of subjective cognitive impairment and probable dementia in the National Health and Aging Trends Study. Alzheimers Dement. 2024 04; 20(4):2817-2829.. View in PubMed
• Diagnoses and Treatment of Behavioral and Psychological Symptoms of Dementia Among Racially and Ethnically Diverse Persons Living with Dementia. J Alzheimers Dis. 2024; 99(2):513-523.. View in PubMed
• Trends in Incident Dementia Diagnosis Before and After Medicare Risk Adjustment. JAMA Netw Open. 2023 12 01; 6(12):e2347708.. View in PubMed
• Health care utilization before and after a dementia diagnosis in Medicare Advantage versus traditional Medicare. J Am Geriatr Soc. 2024 06; 72(6):1856-1866.. View in PubMed
• Estimates of diagnosed dementia prevalence and incidence among diverse beneficiaries in traditional Medicare and Medicare Advantage. Alzheimers Dement (Amst). 2023 Jul-Sep; 15(3):e12472.. View in PubMed
• Expanding the use of brief cognitive assessments to detect suspected early-stage cognitive impairment in primary care. Alzheimers Dement. 2023 09; 19(9):4252-4259.. View in PubMed
• COVID-19 hospitalization and mortality in community-dwelling racially and ethnically diverse persons living with dementia. J Am Geriatr Soc. 2023 05; 71(5):1429-1439.. View in PubMed
• Medicare’s Annual Wellness Visit and diagnoses of dementias and cognitive impairment. Alzheimers Dement (Amst). 2022; 14(1):e12357.. View in PubMed
• Recommendations to address key recruitment challenges of Alzheimer’s disease clinical trials. Alzheimers Dement. 2023 02; 19(2):696-707.. View in PubMed
• Benzodiazepine use and the risk of dementia. Alzheimers Dement (N Y). 2022; 8(1):e12309.. View in PubMed
• Barriers to seeking care for memory problems: A vignette study. Alzheimers Dement (N Y). 2022; 8(1):e12238.. View in PubMed
• Knowledge and Attitudes Concerning Aducanumab Among Older Americans After FDA Approval for Treatment of Alzheimer Disease. JAMA Netw Open. 2022 02 01; 5(2):e2148355.. View in PubMed
• Racial/Ethnic Disparities in Length of Life after Dementia Diagnosis: an 18-Year Follow-up Study of Medicare Beneficiaries. Lancet Reg Health Am. 2022 Apr; 8.. View in PubMed
• Impact of dementia: Health disparities, population trends, care interventions, and economic costs. J Am Geriatr Soc. 2021 07; 69(7):1774-1783.. View in PubMed
• Sex, Race, and Age Differences in Prevalence of Dementia in Medicare Claims and Survey Data. J Gerontol B Psychol Sci Soc Sci. 2021 02 17; 76(3):596-606.. View in PubMed
• Association between exenatide use and incidence of Alzheimer’s disease. Alzheimers Dement (N Y). 2021; 7(1):e12139.. View in PubMed
• Addressing the Diverse Needs of Unpaid Caregivers Through New Health-Care Policy Opportunities. Public Policy Aging Rep. 2021; 31(1):19-23.. View in PubMed
• Statin therapy and risk of Alzheimer’s and age-related neurodegenerative diseases. Alzheimers Dement (N Y). 2020; 6(1):e12108.. View in PubMed
• Changes in physical and mental health of Black, Hispanic, and White caregivers and non-caregivers associated with onset of spousal dementia. Alzheimers Dement (N Y). 2020; 6(1):e12082.. View in PubMed
• Cognitive Assessment At Medicare’s Annual Wellness Visit In Fee-For-Service And Medicare Advantage Plans. Health Aff (Millwood). 2020 11; 39(11):1935-1942.. View in PubMed
• Drug therapies for chronic conditions and risk of Alzheimer’s disease and related dementias: A scoping review. Alzheimers Dement. 2021 01; 17(1):41-48.. View in PubMed
• Alzheimer’s disease and related dementias risk: Comparing users of non-selective and M3-selective bladder antimuscarinic drugs. Pharmacoepidemiol Drug Saf. 2020 12; 29(12):1650-1658.. View in PubMed
• Association of combination statin and antihypertensive therapy with reduced Alzheimer’s disease and related dementia risk. PLoS One. 2020; 15(3):e0229541.. View in PubMed
• Pharmaceutical Treatment for Alzheimer’s Disease and Related Dementias: Utilization and Disparities. J Alzheimers Dis. 2020; 76(2):579-589.. View in PubMed
• Parental Income and Wealth Loss and Transfers to their Young Adult Children. J Fam Econ Issues. 2020 Jun; 41(2):316-331.. View in PubMed
• Longitudinal analysis of dementia diagnosis and specialty care among racially diverse Medicare beneficiaries. Alzheimers Dement. 2019 11; 15(11):1402-1411.. View in PubMed
• Analysis of dementia in the US population using Medicare claims: Insights from linked survey and administrative claims data. Alzheimers Dement (N Y). 2019; 5:197-207.. View in PubMed
• Measuring Alzheimer’s Disease and Other Dementias in Diverse Populations Using Medicare Claims Data. J Alzheimers Dis. 2019; 72(1):29-33.. View in PubMed
• The association of multiple anti-hypertensive medication classes with Alzheimer’s disease incidence across sex, race, and ethnicity. PLoS One. 2018; 13(11):e0206705.. View in PubMed
• Racial and ethnic differences in trends in dementia prevalence and risk factors in the United States. Alzheimers Dement (N Y). 2018; 4:510-520.. View in PubMed
• Generic Drug Price Hikes And Out-Of-Pocket Spending For Medicare Beneficiaries. Health Aff (Millwood). 2018 10; 37(10):1578-1586.. View in PubMed
• Multidimensional comparison of countries’ adaptation to societal aging. Proc Natl Acad Sci U S A. 2018 09 11; 115(37):9169-9174.. View in PubMed
• The Impact of Changes in Population Health and Mortality on Future Prevalence of Alzheimer’s Disease and Other Dementias in the United States. J Gerontol B Psychol Sci Soc Sci. 2018 04 16; 73(suppl_1):S38-S47.. View in PubMed
• Opinion: Measuring how countries adapt to societal aging. Proc Natl Acad Sci U S A. 2018 01 16; 115(3):435-437.. View in PubMed
• Lifetime Consequences of Early-Life and Midlife Access to Health Insurance: A Review. Med Care Res Rev. 2018 12; 75(6):655-720.. View in PubMed
• Strategies for enhancing research in aging health disparities by mentoring diverse investigators. J Clin Transl Sci. 2017 Jun; 1(3):167-175.. View in PubMed
• Sex and Race Differences in the Association Between Statin Use and the Incidence of Alzheimer Disease. JAMA Neurol. 2017 02 01; 74(2):225-232.. View in PubMed
• Raising the Social Security Entitlement Age. Res Aging. 2017 01; 39(1):166-189.. View in PubMed
• Did Medicare Part D reduce disparities? Am J Manag Care. 2015 Feb; 21(2):119-28. Zissimopoulos J , Joyce GF , Scarpati LM, Goldman DP . . View in PubMed
• The Value of Delaying Alzheimer’s Disease Onset. Forum Health Econ Policy. 2014 Nov; 18(1):25-39.. View in PubMed
• Digesting the doughnut hole. J Health Econ. 2013 Dec; 32(6):1345-55.. View in PubMed
• Retirement and health benefits for Mexican migrant workers returning from the United States. Int Soc Secur Rev. 2013 Apr; 66(2):101-125.. View in PubMed
• What Explains the Gender Gap in Financial Literacy? The Role of Household Decision Making. J Consum Aff. 2012; 46(1):90-106.. View in PubMed
• Medical Expenditure Measures in the Health and Retirement Study. Forum Health Econ Policy. 2011 Apr 01; 14(3):4.. View in PubMed
• Employment and self-employment in the wake of Hurricane Katrina. Demography. 2010 May; 47(2):345-67.. View in PubMed
• How Longer Work Lives Ease the Crunch of Population Aging. J Econ Perspect. 2010; 24(1):139-160.. View in PubMed
• The effects of workforce-shaping tools on retirement: the case of the Department of Defense civil service. J Public Health Manag Pract. 2009 Nov; 15(6 Suppl):S64-72.. View in PubMed
• Why Wait?: The Effect of Marriage and Childbearing on the Wages of Men and Women. J Hum Resour. 2009; 44(2):326-349.. View in PubMed
• Labor-Force Dynamics at Older Ages: Movements Into Self-Employment for Workers and Nonworkers. Res Aging. 2009 Jan; 31(1):89-111.. View in PubMed
• High out-of-pocket health care spending by the elderly. Health Aff (Millwood). 2003 May-Jun; 22(3):194-202.. View in PubMed

• Hirsch, Joshua
• Crimmins, Eileen
• Trish, Erin
• Goldman, Dana
• Aisen, Paul
• Joyce, Geoffrey